Spanish researchers develop new immunotherapy combination for liver cancer

FHS
July 1, 2023
3:20 pm

Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer.

CStone’s sugemalimab recommended for metastatic NSCLC

CStone has already secured sugemalimab’s approval in China for five cancer indications. Credit: Marko Aliaksandr/Shutterstock.com. The European Medicines Agency’s (EMA) Committee for Medicinal Products for

June 3, 2024

How AI is Combatting Physician Burnout, Keeping Communities Healthy

David Sides, CEO at NextGen Healthcare Doctors do so much to keep our communities thriving. Unfortunately, according to the American Medical Association, about 63 percent

January 23, 2024

Anti-obesity drugs show promise in improving cardiovascular health beyond weight loss

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American

November 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.